Surgical Science Sweden ABSUSRF -2.20%82 Interest Coverage is 18.46 as of Mar. 2026, which is 65% below its 10-year median of 53.16. GuruFocus rates SUSRF with a GF Score™ of 82/100 and a GF Value™ of $14.30 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 453 Healthcare Providers & Services companies, Surgical Science Sweden AB ranks better than 79.91% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Surgical Science Sweden AB's
Operating Income
for the
three
months ended in Mar. 2026 was $2.5 Mil. Surgical Science Sweden AB's Interest Expense for the
three
months ended in Mar. 2026 was $-0.1 Mil.
Surgical Science Sweden AB's interest coverage for the quarter that ended in Mar. 2026 was 18.46.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Surgical Science Sweden AB has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for Surgical Science Sweden AB's Interest Coverage or its related term are showing as below:
SUSRF'
s Interest Coverage Range Over the Past 10 Years
Min: 10.96 Med: 53.16 Max: 288.34
Current: 54.65
SUSRF's Interest Coverage is ranked better than 79.91% of 453
companies
in the Healthcare Providers & Services industry
Industry Median: 7.98
vs SUSRF: 54.65
Surgical Science Sweden AB (OTCPK:SUSRF) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Surgical Science Sweden AB Interest Coverage Related Terms
Surgical Science Sweden AB Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Surgical Science Sweden AB Interest Coverage Chart
SUSRF vs VEEV, BTSG, TEM: Interest Coverage Comparison
For the Health Information Services subindustry, Surgical Science Sweden AB's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surgical Science Sweden AB Interest Coverage vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Surgical Science Sweden AB's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Surgical Science Sweden AB's Interest Coverage falls into.
Surgical Science Sweden AB Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surgical Science Sweden AB (SUSRF) has a Interest Coverage of 18.46 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Surgical Science Sweden AB and its competitors. This is 65% below median its historical median of 53.16. Over the past decade, Surgical Science Sweden AB's Interest Coverage has ranged from 10.96 to 288.34. According to the industry distribution chart, Surgical Science Sweden AB ranks #91 out of 453 companies in the Healthcare Providers & Services industry, placing it in the top 20.1%.
Is Surgical Science Sweden AB's Interest Coverage too high?
Surgical Science Sweden AB's current Interest Coverage of 18.46 is 65% below median its 10-year median of 53.16. Over the past 10 years, this metric has ranged from a low of 10.96 to a high of 288.34. The Healthcare Providers & Services industry median Interest Coverage is 7.98. Surgical Science Sweden AB's value of 18.46 is 131.3% above this industry median. Based on the distribution chart, Surgical Science Sweden AB ranks #91 out of 453 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Surgical Science Sweden AB has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Surgical Science Sweden AB's Interest Coverage compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Surgical Science Sweden AB ranks #91 out of 453 companies for Interest Coverage. This places Surgical Science Sweden AB in the top 20% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 7.98. Surgical Science Sweden AB's value of 18.46 is 131.3% above this benchmark. Historically, Surgical Science Sweden AB's own Interest Coverage has ranged from 10.96 to 288.34 over the past decade. While the company's 10-year median is 53.16 vs. the industry median of 7.98, Surgical Science Sweden AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Healthcare Providers & Services company?
The median Interest Coverage among Healthcare Providers & Services companies is 7.98, based on 453 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Surgical Science Sweden AB's current Interest Coverage of 18.46 is 131.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Surgical Science Sweden AB and its competitors. For the Healthcare Providers & Services industry, the median Interest Coverage is 7.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Surgical Science Sweden AB's current Interest Coverage is 18.46, which is 65% below median its own 10-year median of 53.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgical Science Sweden AB stock overvalued right now?
Based on GuruFocus' analysis, Surgical Science Sweden AB (SUSRF) is currently considered Significantly Undervalued. The stock's GF Value™ is $14.30, compared to a current price of $4.00 — trading 72% below its estimated fair value. The current Interest Coverage is 18.46, which is 65% below median its 10-year median of 53.16 and 131.3% above the Healthcare Providers & Services industry median of 7.98. Surgical Science Sweden AB's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Surgical Science Sweden AB (SUSRF), the current Interest Coverage is 18.46 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Surgical Science Sweden AB (SUSRF) Overvalued in 2026?
Based on GuruFocus' analysis, Surgical Science Sweden AB stock appears to be undervalued.
The current stock price of $4.00 is trading 72% below its estimated GF Value™ of $14.30.
GuruFocus considers Surgical Science Sweden AB to be Significantly Undervalued.
Key valuation signals for SUSRF:
Interest Coverage: 18.46 (65% below median its 10-year median of 53.16)
GF Value™: $14.30 vs. price of $4.00 (72% below fair value)
Industry Position: 131.3% above the Healthcare Providers & Services median (#91 of 453)
No single metric tells the full story. See the SUSRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Surgical Science Sweden AB is a supplier of virtual reality simulators for medical training. The company's core is its proprietary software and hardware for simulating interactions between instruments and anatomy. It has two operating segments: Educational products include Proprietary brand medical simulator hardware and software for generic training of psycho-motor skills, instrument handling, and training for a large number of procedures and examinations prior to entering the clinical environment, as well as support and services. Industry/OEM includes simulation software for product-specific training of surgeons in robot-assisted surgery and other digitalized medical instruments, and also simulators for medical device companies.
82GF Score
Get the complete analysis for SUSRF
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SUSRF has been successfully added to your 
